Description
The Novo Nordisk Foundation is an international enterprise foundation focusing on medical treatment and research.
In 2022, the foundation had a net worth of $107 billion (805 billion DKK), making it the wealthiest charitable foundation in the world. Novo Nordisk Foundation owns Novo Holdings A/S, a holding company that is the majority voting shareholder of Novo Nordisk, a Danish pharmaceutical corporation.
From 2016 to 2022, the foundation distributed more than US$4.5 billion in grants for research, innovation, treatment, education, humanitarian and social purposes. In 2022, the foundation awarded grants worth $1.09 billion (7.5 billion DKK) and paid out $0.79 billion (5.2 billion DKK).
While the main focus lies within biomedicine and biotechnology research, the Foundation also awards grants for research in general practice and family medicine, nursing and art history.